Melissa Ronan

24PUBLICATIONS
354CO-AUTHORS
Predictive and prognostic markersBiomolecular modelling and designMolecular targetsCheminformatics and quantitative structure-activity relationshipsNeural engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Sep 27, 2026
Histone H4 lysine 20 tri-methylation safeguards breast cancer lineage fidelity and unfolded protein response.

|Sep 23, 2026
A design approach for bitopic kinase inhibitors.

|May 22, 2026
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma.

|Oct 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.

Dejan Juric, Kyung Song, Radia M Johnson

|Oct 03, 2025
Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer.

Jie Luo, Zhixiang Chen, Yuanyuan Qiao

|Sep 03, 2025
An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancer.

Kathleen M McAndrews, Francesca Paradiso, Clint A Stalnecker

Pageof 4

Frequent Collaborators

24 joint publications

Jennifer Roth

23 joint publications

Matthew Rees

6 joint publications

Andrew S Boghossian

4 joint publications

Jacqueline A M Smith